These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10919667)

  • 21. HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells.
    Hsu MC; Chang HC; Hung WC
    Endocr Relat Cancer; 2007 Sep; 14(3):655-67. PubMed ID: 17914096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-gamma-induced dephosphorylation of STAT3 and apoptosis are dependent on the mTOR pathway.
    Fang P; Hwa V; Rosenfeld RG
    Exp Cell Res; 2006 May; 312(8):1229-39. PubMed ID: 16427044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronopharmacology of antitumor effect induced by interferon-beta in tumor-bearing mice.
    Takane H; Ohdo S; Yamada T; Yukawa E; Higuchi S
    J Pharmacol Exp Ther; 2000 Aug; 294(2):746-52. PubMed ID: 10900256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-gamma and its functional receptors overexpression in benign prostatic hyperplasia and prostatic carcinoma: parallelism with c-myc and p53 expression.
    Royuela M; de Miguel MP; Ruiz A; Fraile B; Arenas MI; Romo E; Paniagua R
    Eur Cytokine Netw; 2000 Mar; 11(1):119-27. PubMed ID: 10705309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells.
    Pegram MD; Finn RS; Arzoo K; Beryt M; Pietras RJ; Slamon DJ
    Oncogene; 1997 Jul; 15(5):537-47. PubMed ID: 9247307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The N-terminal 178-amino-acid domain only of the SV40 large T antigen acts as a transforming suppressor of the HER-2/neu oncogene.
    Kao MC; Liu GY; Chuang TC; Lin YS; Wuu JA; Law SL
    Oncogene; 1998 Jan; 16(4):547-54. PubMed ID: 9484845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sodium butyrate enhances STAT 1 expression in PLC/PRF/5 hepatoma cells and augments their responsiveness to interferon-alpha.
    Hung WC; Chuang LY
    Br J Cancer; 1999 May; 80(5-6):705-10. PubMed ID: 10360647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in gene expression induced by phosphorothioate oligodeoxynucleotides (including G3139) in PC3 prostate carcinoma cells are recapitulated at least in part by treatment with interferon-beta and -gamma.
    Benimetskaya L; Wittenberger T; Stein CA; Hofmann HP; Weller C; Lai JC; Miller P; Gekeler V
    Clin Cancer Res; 2004 Jun; 10(11):3678-88. PubMed ID: 15173074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin.
    Zhang L; Chang CJ; Bacus SS; Hung MC
    Cancer Res; 1995 Sep; 55(17):3890-6. PubMed ID: 7543819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of prostate cancer cell division by glucose.
    Singh G; Lakkis CL; Laucirica R; Epner DE
    J Cell Physiol; 1999 Sep; 180(3):431-8. PubMed ID: 10430183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gamma-interferon inhibits Fc receptor II-mediated phagocytosis of tumor cells by human macrophages.
    Backman KA; Guyre PM
    Cancer Res; 1994 May; 54(9):2456-61. PubMed ID: 7909275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
    Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
    Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gamma- and delta-tocotrienols exert a more potent anticancer effect than alpha-tocopheryl succinate on breast cancer cell lines irrespective of HER-2/neu expression.
    Pierpaoli E; Viola V; Pilolli F; Piroddi M; Galli F; Provinciali M
    Life Sci; 2010 Apr; 86(17-18):668-75. PubMed ID: 20188744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxic response of ovarian cancer cell lines to IFN-gamma is associated with sustained induction of IRF-1 and p21 mRNA.
    Burke F; Smith PD; Crompton MR; Upton C; Balkwill FR
    Br J Cancer; 1999 Jun; 80(8):1236-44. PubMed ID: 10376977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-induced increase in sensitivity of ovarian cancer targets to lysis by lymphokine-activated killer cells: selective effects on HER2/neu-overexpressing cells.
    Fady C; Gardner AM; Gera JF; Lichtenstein A
    Cancer Res; 1992 Feb; 52(4):764-9. PubMed ID: 1346583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [SUCI02 inhibits HER-2/neu receptor tyrosine kinase phosphorylation and growth of HER-2/neu-overexpressing breast cancer cells].
    Zhu XF; Liu ZC; Xie BF; Cai LL; Yang DJ
    Ai Zheng; 2003 Aug; 22(8):790-4. PubMed ID: 12917021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of HER2/neu expression induces apoptosis in human cancer cells that overexpress HER2/neu.
    Roh H; Pippin J; Drebin JA
    Cancer Res; 2000 Feb; 60(3):560-5. PubMed ID: 10676637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gamma-interferon reduces expression of the protooncogene c-erbB-2 in human ovarian carcinoma cells.
    Marth C; Müller-Holzner E; Greiter E; Cronauer MV; Zeimet AG; Doppler W; Eibl B; Hynes NE; Daxenbichler G
    Cancer Res; 1990 Nov; 50(21):7037-41. PubMed ID: 2119884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of interferon-gamma on Her-2/neu expression and antitumor activity of 131I-Herceptin in breast cancer cell lines].
    Fan YX; Luo RC; Fang YX; Yan X; Lu CW
    Ai Zheng; 2006 Apr; 25(4):443-6. PubMed ID: 16613677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. STAT1-independent down-regulation of interferon-gamma-induced class II transactivator and HLA-DR expression by transforming growth factor beta-1 in human glomerular endothelial cells.
    Yang WS; Han NJ; Kim CS; Ahn H; Lee SK; Lee KU; Park SK
    Nephron Exp Nephrol; 2005; 100(3):e124-31. PubMed ID: 15824515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.